Liz Galle - 29 Jun 2021 Form 3 Insider Report for CVRx, Inc. (CVRX)

Role
VP of Global Clinical Research
Signature
/s/ Amy C. Seidel, Attorney-in-Fact
Issuer symbol
CVRX
Transactions as of
29 Jun 2021
Net transactions value
$0
Form type
3
Filing time
29 Jun 2021, 21:05:28 UTC
Next filing
20 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVRX Stock Option 29 Jun 2021 Common Stock 758 $0.2370 Direct F1
holding CVRX Stock Option 29 Jun 2021 Common Stock 778 $0.2370 Direct F1
holding CVRX Stock Option 29 Jun 2021 Common Stock 783 $0.2370 Direct F1
holding CVRX Stock Option 29 Jun 2021 Common Stock 758 $0.2370 Direct F1
holding CVRX Stock Option 29 Jun 2021 Common Stock 3,034 $0.2370 Direct F1
holding CVRX Stock Option 29 Jun 2021 Common Stock 13,275 $0.2370 Direct F2
holding CVRX Stock Option 29 Jun 2021 Common Stock 14,538 $0.2370 Direct F3
holding CVRX Stock Option 29 Jun 2021 Common Stock 21,365 $3.96 Direct F4
holding CVRX Stock Option 29 Jun 2021 Common Stock 10,688 $4.35 Direct F1
holding CVRX Stock Option 29 Jun 2021 Common Stock 10,539 $4.35 Direct F5
holding CVRX Stock Option 29 Jun 2021 Common Stock 9,583 $4.35 Direct F6
holding CVRX Stock Option 29 Jun 2021 Common Stock 9,494 $4.35 Direct F7
holding CVRX Stock Option 29 Jun 2021 Common Stock 25,285 $7.12 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested.
F2 Vested as to 25% of the shares on February 26, 2019 and vests as to the 1/48th of the shares each month thereafter.
F3 Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares on the 15th of each month thereafter.
F4 Vested as to 25% of the shares on July 24, 2020 and vests as to 1/48th of the shares each month thereafter.
F5 Vests as to 75% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter.
F6 Vests as to 25% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter.
F7 Vests as to 25% of the shares on October 1, 2021 and as to 1/48th of the shares each month thereafter.
F8 Vests as to 25% of the shares on February 4, 2022 and as to 1/48th of the shares each month thereafter.